Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Zhi Fang, Lin-Yan Wan, Liang-Yin Chu, Yan-Qiong Zhang & Jiang-Feng Wu. (2015) ‘Smart’ nanoparticles as drug delivery systems for applications in tumor therapy. Expert Opinion on Drug Delivery 12:12, pages 1943-1953.
Read now
Read now
Vikas Pandey, Kavita Rai Gajbhiye & Vandana Soni. (2015) Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma. Drug Delivery 22:2, pages 199-205.
Read now
Read now
Jingwei Zhang, Jiali Liu, Yanlei Zhao, Guangji Wang & Fang Zhou. (2015) Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles. Expert Opinion on Drug Delivery 12:2, pages 263-281.
Read now
Read now
Melvin E. Klegerman, Yuejiao Zou, Eva Golunski, Tao Peng, Shao-Ling Huang & David D. McPherson. (2014) Use of thermodynamic coupling between antibody–antigen binding and phospholipid acyl chain phase transition energetics to predict immunoliposome targeting affinity. Journal of Liposome Research 24:3, pages 216-222.
Read now
Read now
Masayasu Kuwahara & Satoshi Obika. (2013) In vitro selection of BNA (LNA) aptamers. Artificial DNA: PNA & XNA 4:2, pages 39-48.
Read now
Read now
Priti P Pednekar, Kisan R Jadhav & Vilasrao J Kadam. (2012) Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging. Expert Opinion on Drug Delivery 9:10, pages 1273-1288.
Read now
Read now
Articles from other publishers (103)
Matthew K. Doherty, Claire Shaw, Leslie Woods & Bart C. Weimer. (2023) Alpha-Gal Bound Aptamer and Vancomycin Synergistically Reduce Staphylococcus aureus Infection In Vivo. Microorganisms 11:7, pages 1776.
Crossref
Crossref
Yadollah Omidi, Jaleh Barar, Somayeh Vandghanooni, Morteza Eskandani & Hossein Omidian. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy
103
139
.
Gleb S. Ivanov, Vyacheslav G. Tribulovich, Nikolay B. Pestov, Temitope I. David, Abdul-Saleem Amoah, Tatyana V. Korneenko & Nikolai A. Barlev. (2022) Artificial genetic polymers against human pathologies. Biology Direct 17:1.
Crossref
Crossref
Luis Jesús Villarreal-Gómez & Graciela Lizeth Pérez-González. 2022. Drug Carriers. Drug Carriers.
Mehrab Pourmadadi, Erfan Rahmani, Amin Shamsabadipour, Shima Mahtabian, Mohammadjavad Ahmadi, Abbas Rahdar & Ana M. Díez-Pascual. (2022) Role of Iron Oxide (Fe2O3) Nanocomposites in Advanced Biomedical Applications: A State-of-the-Art Review. Nanomaterials 12:21, pages 3873.
Crossref
Crossref
Mehrab Pourmadadi, Mohammad Javad Ahmadi, Homayoon Soleimani Dinani, Narges Ajalli & Farid Dorkoosh. (2022) Theranostic Applications of Stimulus-Responsive Systems based on Fe2O3. Pharmaceutical Nanotechnology 10:2, pages 90-112.
Crossref
Crossref
Asghar Narmani & Seid Mahdi Jafari. (2021) Chitosan-based nanodelivery systems for cancer therapy: Recent advances. Carbohydrate Polymers 272, pages 118464.
Crossref
Crossref
Sapna Devi, Neelesh Sharma, Touqeer Ahmed, Zul I. Huma, Savleen Kour, Bijayalaxmi Sahoo, Amit Kumar Singh, Nino Macesic, Sung Jin Lee & Mukesh Kumar Gupta. (2021) Aptamer-based diagnostic and therapeutic approaches in animals: Current potential and challenges. Saudi Journal of Biological Sciences 28:9, pages 5081-5093.
Crossref
Crossref
Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani & Fatemeh Rahbarizadeh. (2021) Aptamer-Assisted Delivery of Nucleotides with Tumor-Suppressing Properties for Targeted Cancer Therapies. Trends in Medical Sciences 1:4.
Crossref
Crossref
Parikshit Moitra, Santosh K. Misra, Krishan Kumar, Paturu Kondaiah, Phuong Tran, Wei Duan & Santanu Bhattacharya. (2021) Cancer Stem Cell-Targeted Gene Delivery Mediated by Aptamer-Decorated pH-Sensitive Nanoliposomes. ACS Biomaterials Science & Engineering 7:6, pages 2508-2519.
Crossref
Crossref
Mohammad Mashreghi, Parvin Zamani, Maryam Karimi, Amin Mehrabian, Mahdieh Arabsalmani, Javad Zarqi, Seyedeh Alia Moosavian & Mahmoud Reza Jaafari. (2021)
Anti‐
epithelial cell adhesion molecule
RNA
aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model
. Biotechnology Progress 37:3.
Crossref
Crossref
Zahra Khoshbin, Mohammad R. Housaindokht, Mohammad Izadyar, Mohammad R. Bozorgmehr & Asma Verdian. (2020) Recent advances in computational methods for biosensor design. Biotechnology and Bioengineering 118:2, pages 555-578.
Crossref
Crossref
Robert Ziółkowski, Marta Jarczewska, Łukasz Górski & Elżbieta Malinowska. (2021) From Small Molecules toward Whole Cells Detection: Application of Electrochemical Aptasensors in Modern Medical Diagnostics. Sensors 21:3, pages 724.
Crossref
Crossref
Aarushi Sharma & Grace Ramena. 2021. Fluorescent Probes. Fluorescent Probes
135
177
.
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy
515
545
.
Niloufar Maghsoudnia, Reza Baradaran Eftekhari, Alireza Naderi Sohi, Ali Zamzami & Farid Abedin Dorkoosh. (2020) Application of nano-based systems for drug delivery and targeting: a review. Journal of Nanoparticle Research 22:8.
Crossref
Crossref
Ruoyao Zhang, Guangle Niu, Qing Lu, Xiaolin Huang, Joe H. C. Chau, Ryan T. K. Kwok, Xiaoqiang Yu, Min-Hui Li, Jacky W. Y. Lam & Ben Zhong Tang. (2020) Cancer cell discrimination and dynamic viability monitoring through wash-free bioimaging using AIEgens. Chemical Science 11:29, pages 7676-7684.
Crossref
Crossref
Ruichen Shen, Jie Tan & Quan Yuan. (2020) Chemically Modified Aptamers in Biological Analysis. ACS Applied Bio Materials 3:5, pages 2816-2826.
Crossref
Crossref
Li-Ping ZHAO, Ge YANG, Xiao-Min ZHANG & Feng QU. (2020) Development of Aptamer Screening against Proteins and Its Applications. Chinese Journal of Analytical Chemistry 48:5, pages 560-572.
Crossref
Crossref
Youli Zu. (2020) Aptamer technology: a new approach to treat lymphoma?. Blood Science 2:1, pages 11-15.
Crossref
Crossref
Magro & Vianello. (2019) Bare Iron Oxide Nanoparticles: Surface Tunability for Biomedical, Sensing and Environmental Applications. Nanomaterials 9:11, pages 1608.
Crossref
Crossref
Marzieh Akbarzadeh, Maryam Babaei, Khalil Abnous, Seyed Mohammad Taghdisi, Mohammad Taghi Peivandi, Mohammad Ramezani & Mona Alibolandi. (2019) Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. International Journal of Pharmaceutics 570, pages 118645.
Crossref
Crossref
Jianhua Yan, Hongjie Xiong, Shundong Cai, Nachuan Wen, Qunye He, Yanfei Liu, Dongming Peng & Zhenbao Liu. (2019) Advances in aptamer screening technologies. Talanta 200, pages 124-144.
Crossref
Crossref
Yasen Maimaitiyiming, De Fei Hong, Chang Yang & Hua Naranmandura. (2019) Novel insights into the role of aptamers in the fight against cancer. Journal of Cancer Research and Clinical Oncology 145:4, pages 797-810.
Crossref
Crossref
Mahsa Ramezanpour, Puyan Daei, Maryam Tabarzad, Korosh Khanaki, Ali Elmi & Mahmood Barati. (2018) Preliminary study on the effect of nucleolin specific aptamer–miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells. Molecular Biology Reports 46:1, pages 207-215.
Crossref
Crossref
Shuanghui Yang, Huan Li, Ling Xu, Zhenhan Deng, Wei Han, Yanting Liu, Wenqi Jiang & Youli Zu. (2018) Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies. Molecular Therapy - Nucleic Acids 13, pages 164-175.
Crossref
Crossref
Simranjeet Singh Sekhon, Gna Ahn, Satpal Singh Sekhon, Ji-Young Ahn & Yang-Hoon Kim. (2018) Bioengineered aptamer-nanoconjugates for cancer theragnosis. Molecular & Cellular Toxicology 14:4, pages 361-368.
Crossref
Crossref
Gang Zhou, Olivier Latchoumanin, Lionel Hebbard, Wei Duan, Christopher Liddle, Jacob George & Liang Qiao. (2018) Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers. Advanced Drug Delivery Reviews 134, pages 107-121.
Crossref
Crossref
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar & Yadollah Omidi. (2018) Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective. Journal of Molecular Medicine 96:9, pages 885-902.
Crossref
Crossref
Juan David Ospina-Villa, Alexandre Dufour, Christian Weber, Esther Ramirez-Moreno, Absalom Zamorano-Carrillo, Nancy Guillen, César Lopez-Camarillo & Laurence A. Marchat. (2018) Targeting the polyadenylation factor EhCFIm25 with RNA aptamers controls survival in Entamoeba histolytica. Scientific Reports 8:1.
Crossref
Crossref
Ye Zhang, Veronica Lyons & Dimitri Pappas. (2018) Fundamentals of affinity cell separations. ELECTROPHORESIS 39:5-6, pages 732-741.
Crossref
Crossref
Nithya Subramanian, Akilandeswari Balachandran & Krishnakumar Subramanian. 2018. Gene and Cell Therapy: Biology and Applications. Gene and Cell Therapy: Biology and Applications
147
194
.
Enora Prado, Mónika Ádok-Sipiczki & Corinne Nardin. 2017. Bionanocomposites. Bionanocomposites
93
112
.
Carlos E.B. de Almeida, Lais Nascimento Alves, Henrique F. Rocha, Januário Bispo Cabral-Neto & Sotiris Missailidis. (2017) Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer. International Journal of Pharmaceutics 525:2, pages 334-342.
Crossref
Crossref
Mario Martínez Soldevilla, Helena Villanueva & Fernando Pastor. 2017. Immunotherapy - Myths, Reality, Ideas, Future. Immunotherapy - Myths, Reality, Ideas, Future.
Ece Bayir, Eyup Bilgi & Aylin Sendemir Urkmez. 2017. Pharmaceutical Sciences. Pharmaceutical Sciences
1212
1257
.
Marianna Rossetti, Simona Ranallo, Andrea Idili, Giuseppe Palleschi, Alessandro Porchetta & Francesco Ricci. (2017) Allosteric DNA nanoswitches for controlled release of a molecular cargo triggered by biological inputs. Chemical Science 8:2, pages 914-920.
Crossref
Crossref
Rafael R. Castillo, Alejandro Baeza & María Vallet-Regí. (2017) Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors. Biomaterials Science 5:3, pages 353-377.
Crossref
Crossref
R. Mankamna Kumari, Nidhi Gupta & Surendra Nimesh. 2017. Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids. Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids
113
134
.
Caroline Coleman-Vaughan, Arijit Mal, Abhijit De & Justin V. McCarthy. 2017. Pathophysiological Aspects of Proteases. Pathophysiological Aspects of Proteases
47
87
.
Jayanth Suryanarayanan Shankaranarayanan, Jagat R. Kanwar, Afrah Jalil Abd AL-Juhaishi & Rupinder K. Kanwar. (2016) Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice. Scientific Reports 6:1.
Crossref
Crossref
Abbas Ali Imani Fooladi, Mojtaba Hedayati Ch, Mohsen Amin & Jafar Amani. (2016) Applications and modifications of aptamers: potential tool for medical microbiology. Reviews in Medical Microbiology 27:3, pages 107-120.
Crossref
Crossref
Anila Mathew & D Kumar. 2016. Aptamers. Aptamers
187
222
.
Marlies Gijs, An Aerts, Nathalie Impens, Sarah Baatout & André Luxen. (2016) Aptamers as radiopharmaceuticals for nuclear imaging and therapy. Nuclear Medicine and Biology 43:4, pages 253-271.
Crossref
Crossref
Jagat R Kanwar, Sishir K Kamalapuram, Subramanian Krishnakumar & Rupinder K Kanwar. (2016)
Multimodal iron oxide (Fe
3
O
4
)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER
-
/PR
-
/HER2
-
)
. Nanomedicine 11:3, pages 249-268.
Crossref
Crossref
M. M. Soldevilla, H. Villanueva & F. Pastor. (2016) Aptamers: A Feasible Technology in Cancer Immunotherapy. Journal of Immunology Research 2016, pages 1-12.
Crossref
Crossref
Resham Chaudhary, Kislay Roy, Rupinder K. Kanwar, Rakesh N. Veedu, Subramanian Krishnakumar, Chun Hei Antonio Cheung, Anita K. Verma & Jagat R. Kanwar. (2016) E-Cadherin Aptamer-Conjugated Delivery of Doxorubicin for Targeted Inhibition of Prostate Cancer Cells. Australian Journal of Chemistry 69:10, pages 1108.
Crossref
Crossref
Raj Kumar Thapa, Ju Yeon Choi, Biki Gupta, Thiruganesh Ramasamy, Bijay Kumar Poudel, Sae Kwang Ku, Yu Seok Youn, Han Gon Choi, Chul Soon Yong & Jong Oh Kim. (2016) Liquid crystalline nanoparticles encapsulating cisplatin and docetaxel combination for targeted therapy of breast cancer. Biomaterials Science 4:9, pages 1340-1350.
Crossref
Crossref
Paloma Rodriguez, M Isabel Pérez-Morgado, Víctor M Gonzalez, M Elena Martín & Amelia Nieto. (2016) Inhibition of Influenza Virus Replication by DNA Aptamers Targeting a Cellular Component of Translation Initiation. Molecular Therapy - Nucleic Acids 5, pages e308.
Crossref
Crossref
Nithya Subramanian, Jagat R Kanwar, Prasanna kumar Athalya, Narayanan Janakiraman, Vikas Khetan, Rupinder K Kanwar, Sailaja Eluchuri & Subramanian Krishnakumar. (2015) EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex. Journal of Biomedical Science 22:1.
Crossref
Crossref
Nithya SubramanianJagat R. KanwarRupinder K. KanwarSubramanian Krishnakumar. (2015) Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras. Nucleic Acid Therapeutics 25:6, pages 317-322.
Crossref
Crossref
Kislay Roy, Rupinder K. Kanwar & Jagat R. Kanwar. (2015) LNA aptamer based multi-modal, Fe 3 O 4 -saturated lactoferrin (Fe 3 O 4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging. Biomaterials 71, pages 84-99.
Crossref
Crossref
Gregory Benedetto, C. Greer Vestal & Christine Richardson. (2015) Aptamer-Functionalized Nanoparticles as “Smart Bombs”: The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment. Targeted Oncology 10:4, pages 467-485.
Crossref
Crossref
Nihal G. Maremanda, Kislay Roy, Rupinder K. Kanwar, Vidyarani Shyamsundar, Vijayalakshmi Ramshankar, Arvind Krishnamurthy, Subramanian Krishnakumar & Jagat R. Kanwar. (2015) Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells. Biomicrofluidics 9:5.
Crossref
Crossref
Dmitrii S. Shcherbinin, Oksana V. Gnedenko, Svetlana A. Khmeleva, Sergey A. Usanov, Andrei A. Gilep, Aliaksei V. Yantsevich, Tatsiana V. Shkel, Ivan V. Yushkevich, Sergey P. Radko, Alexis S. Ivanov, Alexander V. Veselovsky & Alexander I. Archakov. (2015) Computer-aided design of aptamers for cytochrome p450. Journal of Structural Biology 191:2, pages 112-119.
Crossref
Crossref
Nithya Subramanian, Jagat R. Kanwar, Rupinder K. Kanwar, JagadeeshBabu Sreemanthula, Jyotirmay Biswas, Vikas Khetan & Subramanian Krishnakumar. (2015) EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer. PLOS ONE 10:7, pages e0132407.
Crossref
Crossref
Onat Kadioglu, Anna Helena Malczyk, Henry Johannes Greten & Thomas Efferth. (2015) Aptamers as a novel tool for diagnostics and therapy. Investigational New Drugs 33:2, pages 513-520.
Crossref
Crossref
Francesca Bonafè, Carlo Guarnieri & Claudio Muscari. (2015) Cancer stem cells and mesenchymal stem cells in the hypoxic tumor niche: Two different targets for one only drug. Medical Hypotheses 84:3, pages 227-230.
Crossref
Crossref
Jiafeng Qi, Huiling Li, Nanbo Liu, Yutong Xing, Gang Zhou, Yao Wu, Yuanhang Liu, Wenxia Chen, Jie Yue, Bater Han, Shirong Kang & Xu Wu. (2015) The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas. Medical Oncology 32:3.
Crossref
Crossref
Manasi Das, Wei Duan & Sanjeeb K. Sahoo. (2015) Multifunctional nanoparticle?EpCAM aptamer bioconjugates: A paradigm for targeted drug delivery and imaging in cancer therapy. Nanomedicine: Nanotechnology, Biology and Medicine 11:2, pages 379-389.
Crossref
Crossref
ENZO AGOSTINELLI, FABIO VIANELLO, GIUSEPPE MAGLIULO, THRESIA THOMAS & T.J. THOMAS. (2015) Nanoparticle strategies for cancer therapeutics: Nucleic acids, polyamines, bovine serum amine oxidase and iron oxide nanoparticles (Review). International Journal of Oncology 46:1, pages 5-16.
Crossref
Crossref
Kislay Roy, Rupinder K. Kanwar, Chun Hei Antonio Cheung, Cassandra Lee Fleming, Rakesh N. Veedu, Subramanian Krishnakumar & Jagat R. Kanwar. (2015) Locked nucleic acid modified bi-specific aptamer-targeted nanoparticles carrying survivin antagonist towards effective colon cancer therapy. RSC Advances 5:37, pages 29008-29016.
Crossref
Crossref
Hamed Arami, Amit Khandhar, Denny Liggitt & Kannan M. Krishnan. (2015) In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chemical Society Reviews 44:23, pages 8576-8607.
Crossref
Crossref
Nithya Subramanian, Jagat R. Kanwar, Balachandran Akilandeswari, Rupinder K. Kanwar, Vikas Khetan & Subramanian Krishnakumar. (2015) Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery. Chemical Communications 51:32, pages 6940-6943.
Crossref
Crossref
Darija Muharemagic & Maxim V. Berezovski. 2015. RNA and DNA Diagnostics. RNA and DNA Diagnostics
107
121
.
William H. Thiel, Kristina W. Thiel, Katie S. Flenker, Tom Bair, Adam J. Dupuy, James O. McNamaraIIII, Francis J. Miller & Paloma H. Giangrande. 2015. RNA Interference. RNA Interference
187
199
.
Yang Gao & Zhou Yuan. (2014) Nanotechnology for the detection and kill of circulating tumor cells. Nanoscale Research Letters 9:1.
Crossref
Crossref
Ling-Yuan Kong, Jun Wei, Ali S. Haider, Brandon D. Liebelt, Xiaoyang Ling, Charles A. Conrad, Gregory N. Fuller, Nicholas B. Levine, Waldemar Priebe, Raymond Sawaya & Amy B. Heimberger. (2014) Therapeutic targets in subependymoma. Journal of Neuroimmunology 277:1-2, pages 168-175.
Crossref
Crossref
Jagat R. Kanwar, Jayanth Suryanarayanan Shankaranarayanan, Sneha Gurudevan & Rupinder K. Kanwar. (2014) Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases. Drug Discovery Today 19:9, pages 1309-1321.
Crossref
Crossref
Wan-Ming Li, Tao Bing, Jia-Yi Wei, Zhe-Zhou Chen, Di-Hua Shangguan & Jin Fang. (2014) Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells. Biomaterials 35:25, pages 6998-7007.
Crossref
Crossref
Yu Gao, Jingjing Xie, Haijun Chen, Songen Gu, Rongli Zhao, Jingwei Shao & Lee Jia. (2014) Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnology Advances 32:4, pages 761-777.
Crossref
Crossref
Yuanyuan Wang, Yun Luo, Tao Bing, Zheng Chen, Minhua Lu, Nan Zhang, Dihua Shangguan & Xin Gao. (2014) DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer. PLoS ONE 9:6, pages e100243.
Crossref
Crossref
Olivier MartínezElisabeth BellardMuriel GolzioSaad Mechiche-AlamiMarie-Pierre RolsJustin TeissiéVincent EcochardLaurent Paquereau. (2014) Direct Validation of Aptamers as Powerful Tools to Image Solid Tumor. Nucleic Acid Therapeutics 24:3, pages 217-225.
Crossref
Crossref
Sailen Barik & Vira Bitko. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine
1
39
.
Jonathan W. Kotula, Jinpeng Sun, Margie Li, Elizabeth D. Pratico, Mark P. Fereshteh, Douglas P. Ahrens, Bruce A. Sullenger & Jeffrey J. Kovacs. (2014) Targeted Disruption of ?-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth. PLoS ONE 9:4, pages e93441.
Crossref
Crossref
Irene Russo Krauss, Gary Nigel Parkinson, Antonello Merlino, Carlo Andrea Mattia, Antonio Randazzo, Ettore Novellino, Lelio Mazzarella & Filomena Sica. (2014) A regular thymine tetrad and a peculiar supramolecular assembly in the first crystal structure of an all-LNA G-quadruplex. Acta Crystallographica Section D Biological Crystallography 70:2, pages 362-370.
Crossref
Crossref
Ece Bayir, Eyup Bilgi & Aylin Sendemir Urkmez. 2014. Handbook of Research on Nanoscience, Nanotechnology, and Advanced Materials. Handbook of Research on Nanoscience, Nanotechnology, and Advanced Materials
447
491
.
Md. Ashrafuzzaman. (2014) Aptamers as Both Drugs and Drug-Carriers. BioMed Research International 2014, pages 1-21.
Crossref
Crossref
Vivek K. Sharma, Pallavi Rungta & Ashok K. Prasad. (2014) Nucleic acid therapeutics: basic concepts and recent developments. RSC Advances 4:32, pages 16618.
Crossref
Crossref
Lien-Yu Hung, Chih-Hung Wang, Keng-Fu Hsu, Cheng-Yang Chou & Gwo-Bin Lee. (2014) An on-chip Cell-SELEX process for automatic selection of high-affinity aptamers specific to different histologically classified ovarian cancer cells. Lab Chip 14:20, pages 4017-4028.
Crossref
Crossref
Nithya SubramanianJagadeesh Babu Sreemanthula, Baghavathi Balaji, Jagat R. Kanwar, Jyotirmay Biswas & Subramanian Krishnakumar. (2014) A strain-promoted alkyne–azide cycloaddition (SPAAC) reaction of a novel EpCAM aptamer–fluorescent conjugate for imaging of cancer cells. Chem. Commun. 50:80, pages 11810-11813.
Crossref
Crossref
Richard Conroy & Belinda Seto. 2014. Engineering in Translational Medicine. Engineering in Translational Medicine
475
512
.
Claudio Muscari, Emanuele Giordano, Francesca Bonafè, Marco Govoni, Alice Pasini & Carlo Guarnieri. (2013) Molecular mechanisms of ischemic preconditioning and postconditioning as putative therapeutic targets to reduce tumor survival and malignancy. Medical Hypotheses 81:6, pages 1141-1145.
Crossref
Crossref
Swati Dawar, Neha Singh, Rupinder K. Kanwar, Richard Lee Kennedy, Rakesh N. Veedu, Shu-Feng Zhou, Subramanian Krishnakumar, Sarbani Hazra, Sreenivasan Sasidharan, Wei Duan & Jagat R. Kanwar. (2013) Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers. Drug Discovery Today 18:23-24, pages 1292-1300.
Crossref
Crossref
Ka-To Shum, Jiehua Zhou & John Rossi. (2013) Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases. Pharmaceuticals 6:12, pages 1507-1542.
Crossref
Crossref
Francesco Puoci, Silke Hampel, Ortensia ilaria Parisi, Abdelwahab Hassan, Giuseppe Cirillo & Nevio Picci. (2013) Imprinted microspheres doped with carbon nanotubes as novel electroresponsive drug-delivery systems. Journal of Applied Polymer Science 130:2, pages 829-834.
Crossref
Crossref
V. G. Metelev, E. A. Kubareva & T. S. Oretskaya. (2013) Regulation of activity of transcription factor NF-κB by synthetic oligonucleotides. Biochemistry (Moscow) 78:8, pages 867-878.
Crossref
Crossref
Jagat R. Kanwar, Sishir K. Kamalapuram & Rupinder K. Kanwar. (2013) Survivin Signaling in Clinical Oncology: A Multifaceted Dragon. Medicinal Research Reviews 33:4, pages 765-789.
Crossref
Crossref
Yuri Imaizumi, Yuuya Kasahara, Hiroto Fujita, Shunsuke Kitadume, Hiroaki Ozaki, Tamaki Endoh, Masayasu Kuwahara & Naoki Sugimoto. (2013) Efficacy of Base-Modification on Target Binding of Small Molecule DNA Aptamers. Journal of the American Chemical Society 135:25, pages 9412-9419.
Crossref
Crossref
Jillian F. WiseZuzana BerkovaRohit MathurHaifeng ZhuFrank K. BraunRong-Hua TaoAnita L. Sabichi, Xue AoHoyoung MaengFelipe Samaniego. (2013) Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. Blood 121:23, pages 4729-4739.
Crossref
Crossref
Yanyun Wang, Feng Zhou, Xiaoli Liu, Lin Yuan, Dan Li, Yanwei Wang & Hong Chen. (2013) Aptamer-Modified Micro/Nanostructured Surfaces: Efficient Capture of Ramos Cells in Serum Environment. ACS Applied Materials & Interfaces 5:9, pages 3816-3823.
Crossref
Crossref
Yanling Song, Zhi Zhu, Yuan An, Weiting Zhang, Huimin Zhang, Dan Liu, Chundong Yu, Wei Duan & Chaoyong James Yang. (2013) Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture. Analytical Chemistry 85:8, pages 4141-4149.
Crossref
Crossref
Meidi Hu & Kunhe Zhang. (2013) The application of aptamers in cancer research: an up-to-date review. Future Oncology 9:3, pages 369-376.
Crossref
Crossref
KuanCan Liu, BaoShun Lin & XiaoPeng Lan. (2012) Aptamers: A promising tool for cancer imaging, diagnosis, and therapy. Journal of Cellular Biochemistry 114:2, pages 250-255.
Crossref
Crossref
Ka-To Shum & John J. Rossi. 2013. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases
395
423
.
Ka-To Shum & John J. Rossi. 2013. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases
395
423
.
Holger Doessing, Lykke Hansen, Rakesh Veedu, Jesper Wengel & Birte Vester. (2012) Amplification and Re-Generation of LNA-Modified Libraries. Molecules 17:11, pages 13087-13097.
Crossref
Crossref
David H. J. Bunka & Peter G. Stockley. 2012. DNA Conjugates and Sensors. DNA Conjugates and Sensors
140
165
.
Jagat R KanwarGanesh Mahidhara & Rupinder K Kanwar. (2012) Novel alginate-enclosed chitosan–calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy. Nanomedicine 7:10, pages 1521-1550.
Crossref
Crossref
Jagat R. Kanwar, Jessica Gibbons, Anita K. Verma & Rupinder K. Kanwar. (2012) Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide. Anti-Cancer Drugs 23:5, pages 471-482.
Crossref
Crossref
Sailen Barik & Vira Bitko. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Sarah ShigdarJia LinYong Li, Chaoyong James Yang, Mingqian Wei, Yimin Zhu, Hui Liu & Wei Duan. (2012) Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging. Therapeutic Delivery 3:2, pages 227-244.
Crossref
Crossref
Jagat R. Kanwar, Rupinder K. Kanwar, Ganesh Mahidhara & Chun Hei Antonio Cheung. (2012) Cancer Targeted Nanoparticles Specifically Induce Apoptosis in Cancer Cells and Spare Normal Cells. Australian Journal of Chemistry 65:1, pages 5.
Crossref
Crossref